One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Safe and effective cancer care: how long must we wait?
doi : 10.1016/S1470-2045(24)00097-4
Volume 25, Issue 3, March 2024, Page 265
A pan-European total cancer prevalence canvas: a benchmark for advancing strategic interventions
Shahrokh F Shariat
doi : 10.1016/S1470-2045(24)00089-5
Volume 25, Issue 3, March 2024, Pages 266-267
Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
Daniel X Yang, *Raquibul Hannan
doi : 10.1016/S1470-2045(24)00083-4
Volume 25, Issue 3, March 2024, Pages 267-269
Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer
Nan Chen, *Rita Nanda
doi : 10.1016/S1470-2045(24)00080-9
Volume 25, Issue 3, March 2024, Pages 269-270
Endpoints in human papillomavirus-related oropharyngeal cancer trials
*Marshall Posner, Scott A Roof
doi : 10.1016/S1470-2045(24)00065-2
Volume 25, Issue 3, March 2024, Pages 270-272
Antibody–drug conjugates in acute myeloid leukaemia: more research needed
Sabine Kayser
doi : 10.1016/S1470-2045(24)00014-7
Volume 25, Issue 3, March 2024, Pages 272-273
The need for speed: recovering undersampled MRI scans for glioma imaging
*Frederik Barkhof, Geoff JM Parker
doi : 10.1016/S1470-2045(24)00036-6
Volume 25, Issue 3, March 2024, Pages 274-275
Data sharing in cancer research: perceived risks and the consequences of not sharing
James T Topham, Rita T Lawlor, Diana Lemaire, Raffaella Casolino, *Andrew V Biankin
doi : 10.1016/S1470-2045(24)00021-4
Volume 25, Issue 3, March 2024, Pages 275-276
The Radiation Planning Assistant: addressing the global gap in radiotherapy services
Laurence E Court
doi : 10.1016/S1470-2045(24)00084-6
Volume 25, Issue 3, March 2024, Pages 277-278
Accurately addressing double-arm-zero-events studies in meta-analyses
Qi Zhou, *Yaolong Chen
doi : 10.1016/S1470-2045(24)00008-1
Volume 25, Issue 3, March 2024, Page e92
Accurately addressing double-arm-zero-events studies in meta-analyses – Authors' reply
Yu Fujiwara, Nobuyuki Horita, Abdul Rafeh Naqash
doi : 10.1016/S1470-2045(24)00009-3
Volume 25, Issue 3, March 2024, Page e93
CALLA trial: immunotherapy in locally advanced cervical cancer
Fadila Kouhen, Mohammed Sqali Houssaini
doi : 10.1016/S1470-2045(23)00648-4
Volume 25, Issue 3, March 2024, Page e94
CALLA trial: immunotherapy in locally advanced cervical cancer
Xi Yang, Yuanyuan Zhang, Shuangzheng Jia, Jusheng An, *Manni Huang
doi : 10.1016/S1470-2045(24)00006-8
Volume 25, Issue 3, March 2024, Page e95
CALLA trial: immunotherapy in locally advanced cervical cancer – Authors' reply
Bradley J Monk, Jyoti Mayadev
doi : 10.1016/S1470-2045(24)00098-6
Volume 25, Issue 3, March 2024, Page e96
Uncovering causal clues in the development of second primary cancers
*Huan Yi, Jianguang Ji
doi : 10.1016/S1470-2045(23)00675-7
Volume 25, Issue 3, March 2024, Page e97
Uncovering causal clues in the development of second primary cancers – Authors' reply
Trille Kristina Kjaer, Christoffer Johansen, Susanne Oksbjerg Dalton
doi : 10.1016/S1470-2045(24)00090-1
Volume 25, Issue 3, March 2024, Page e98
Optimal imaging before local therapy of colorectal liver metastases
Antony Haddad, Mateo Lendoire, Iwan Paolucci, HyunSeon Christine Kang, *Jean-Nicolas Vauthey
doi : 10.1016/S1470-2045(24)00039-1
Volume 25, Issue 3, March 2024, Page e99
Optimal imaging before local therapy of colorectal liver metastases
Vincenza Granata, Antonella Petrillo, Sergio Venanzio Setola, Francesco Izzo, Roberta Fusco
doi : 10.1016/S1470-2045(24)00033-0
Volume 25, Issue 3, March 2024, Page e100
Optimal imaging before local therapy of colorectal liver metastases – Authors' reply
Burak G?rgec, Jasper P Sijberden, Rutger-Jan Swijnenburg, ?smund A Fretland, Cornelis Verhoef, Marc G Besselink, *Jaap Stoker
doi : 10.1016/S1470-2045(24)00093-7
Volume 25, Issue 3, March 2024, Page e101
Correction to Lancet Oncol 2023; 24: 483–95
doi : 10.1016/S1470-2045(24)00018-4
Volume 25, Issue 3, March 2024, Page e102
Substance use disorders among cancer survivors
Sharmila Devi
doi : 10.1016/S1470-2045(24)00042-1
Volume 25, Issue 3, March 2024, Page 279
IAEA site visit to the Zaporizhzhya Nuclear Power Plant in Ukraine
Manjulika Das
doi : 10.1016/S1470-2045(24)00073-1
Volume 25, Issue 3, March 2024, Page 280
HPV vaccination programme success in Scotland
Talha Burki
doi : 10.1016/S1470-2045(24)00074-3
Volume 25, Issue 3, March 2024, Page 281
Horizon 2020 evaluation highlights benefit of cross-border research but points to areas for improvement
Emma Wilkinson
doi : 10.1016/S1470-2045(24)00086-X
Volume 25, Issue 3, March 2024, Pages 282-283
BRCA testing launched for people of Jewish ancestry in England
Priya Venkatesan
doi : 10.1016/S1470-2045(24)00087-1
Volume 25, Issue 3, March 2024, Page 284
Children and Young People Cancer Taskforce
Talha Burki
doi : 10.1016/S1470-2045(24)00096-2
Volume 25, Issue 3, March 2024, Page e103
Strategies to promote sustainable care for children with cancer in Ukraine
Asya Agulnik, Yuliya Nogovitsyna, Roman Kizyma, Taisiya Yakimkova, Victoria Vivtcharenko, Nickhill Bhakta, Paul H Wise, Carlos Rodriguez-Galindo, Arman Kacharian
doi : 10.1016/S1470-2045(23)00577-6
Volume 25, Issue 3, March 2024, Pages 285-288
Design and implementation of a humanitarian cancer care programme for Ukrainian refugees in Moldova and Romania
Horia Vulpe, Artiom Minzatean, Irena Tocino, Ruslan Baltaga, Gabriel Kacso, Claudia Oprea, Veronica Ciobanu, Sergiu Brenister, Ciprian Tomuleasa, Gabriel Ricu, Rodica Mindruta-Stratan, Catalin Danaila, Dragos Iancu, Ludmila Circiumari, Cristian Teglas, Lars Lonnback, Violina Nazaria, Ursula Wagner, Eugenia Ciubotaru, Nicoleta Minzatean, Ciprian Jitaru, Stanislav Polozov, Inessa Matiushenko, Anna Uzlova, Richard Sullivan, Stefania Magidson
doi : 10.1016/S1470-2045(23)00629-0
Volume 25, Issue 3, March 2024, Pages 289-291
Joseph Lubega, Director of Global HOPE—building paediatric cancer care in sub-Saharan Africa
Emma Wilkinson
doi : 10.1016/S1470-2045(24)00077-9
Volume 25, Issue 3, March 2024, Page 292
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
Roberta De Angelis, Elena Demuru, Paolo Baili, Xavier Troussard, Alexander Katalinic, Maria Dolores Chirlaque Lopez, Kaire Innos, Mariano Santaquilani, Marcel Blum, Leonardo Ventura, Keiu Paapsi, Rocco Galasso, Marcela Guevara, Giorgia Randi, Manola Bettio, Laura Botta, Stefano Guzzinati, Luigino Dal Maso, Silvia Rossi, on behalf of the EUROCARE-6 Working Group
doi : 10.1016/S1470-2045(23)00646-0
Volume 25, Issue 3, March 2024, Pages 293-307
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
Shankar Siva, Mathias Bressel, Mark Sidhom, Swetha Sridharan, Ben G L Vanneste, Ryan Davey, Rebecca Montgomery, Jeremy Ruben, Farshad Foroudi, Braden Higgs, Charles Lin, Avi Raman, Nicholas Hardcastle, Michael S Hofman, Richard De Abreu Lourenco, Mark Shaw, Pascal Mancuso, Daniel Moon, Lih-Ming Wong, Nathan Lawrentschuk, Simon Wood, Nicholas R Brook, Tomas Kron, Jarad Martin, David Pryor, together with the FASTRACK II Investigator Group
doi : 10.1016/S1470-2045(24)00020-2
Volume 25, Issue 3, March 2024, Pages 308-316
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
Carlo Palmieri, Hannah Linden, Stephen N Birrell, Sally Wheelwright, Elgene Lim, Lee S Schwartzberg, Amy R Dwyer, Theresa E Hickey, Hope S Rugo, Patrick Cobb, Joyce A O’Shaughnessy, Stephen Johnston, Adam Brufsky, Wayne D Tilley*, Beth Overmoyer
doi : 10.1016/S1470-2045(24)00004-4
Volume 25, Issue 3, March 2024, Pages 317-325
The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study
Pieter H A Wisse*, Willemijn de Klaver*, Francine van Wifferen, Frejanne G van Maaren-Meijer, Huub E van Ingen, Lana Meiqari, Iris Huitink, Mariska Bierkens, Margriet Lemmens, Marjolein J E Greuter, Monique E van Leerdam, Manon C W Spaander, Evelien Dekker, Veerle M H Coupé, Beatriz Carvalho, Meike de Wit, Gerrit A Meijer
doi : 10.1016/S1470-2045(23)00651-4
Volume 25, Issue 3, March 2024, Pages 326-337
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study
Sean McPhail, Matthew E Barclay, Shane A Johnson*, Ruth Swann*, Riaz Alvi, Andriana Barisic, Oliver Bucher, Nicola Creighton, Cheryl A Denny, Ron A Dewar, David W Donnelly, Jeff J Dowden, Laura Downie, Norah Finn, Anna T Gavin, Steven Habbous, Dyfed W Huws, Leon May, Carol A McClure, Bj?rn M?ller, Grace Musto, Yngvar Nilssen, Nathalie Saint-Jacques, Sabuj Sarker, Lorraine Shack, Xiaoyi Tian, Robert J S Thomas, Catherine S Thomson, Haiyan Wang, Ryan R Woods, Hui You, Georgios Lyratzopoulos, ICBP Module 9 Chemotherapy Groupâ€
doi : 10.1016/S1470-2045(24)00031-7
Volume 25, Issue 3, March 2024, Pages 338-351
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study
Sean McPhail, Matthew E Barclay, Ruth Swann*, Shane A Johnson*, Riaz Alvi, Andriana Barisic, Oliver Bucher, Nicola Creighton, Cheryl A Denny, Ron A Dewar, David W Donnelly, Jeff J Dowden, Laura Downie, Norah Finn, Anna T Gavin, Steven Habbous, Dyfed W Huws, S Eshwar Kumar, Leon May, Carol A McClure, David S Morrison, Bj?rn M?ller, Grace Musto, Yngvar Nilssen, Nathalie Saint-Jacques, Sabuj Sarker, Lorraine Shack, Xiaoyi Tian, Robert JS Thomas, Haiyan Wang, Ryan R Woods, Hui You, Bin Zhang, Georgios Lyratzopoulos, ICBP Module 9 Radiotherapy Group
doi : 10.1016/S1470-2045(24)00032-9
Volume 25, Issue 3, March 2024, Pages 352-365
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis
Laila A Gharzai*, Emily Morris*, Krithika Suresh, Phuc Felix Nguyen-Tân, David I Rosenthal, Maura L Gillison, Paul M Harari, Adam S Garden, Shlomo Koyfman, Jimmy J Caudell, Christopher U Jones, Darrion L Mitchell, Greg Krempl, John A Ridge, Michael F Gensheimer, James A Bonner, Edith Filion, Neal E Dunlap, William A Stokes, Quynh-Thu Le, Pedro Torres-Saavedra, Michelle Mierzwa*, Matthew J Schipper
doi : 10.1016/S1470-2045(24)00016-0
Volume 25, Issue 3, March 2024, Pages 366-375
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Kris Michael Mahadeo, Robert Baiocchi, Amer Beitinjaneh, Sridhar Chaganti, Sylvain Choquet, Daan Dierickx, Rajani Dinavahi, Xinyuan Duan, Laurence Gamelin, Armin Ghobadi, Norma Guzman-Becerra, Manher Joshi, Aditi Mehta, Willis H Navarro, Sarah Nikiforow, Richard J O’Reilly, Ran Reshef, Fiona Ruiz, Tassja Spindler, Susan Prockop
doi : 10.1016/S1470-2045(23)00649-6
Volume 25, Issue 3, March 2024, Pages 376-387
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
Naval G Daver, Pau Montesinos, Daniel J DeAngelo, Eunice S Wang, Nikolaos Papadantonakis, Elisabetta Todisco, Kendra L Sweet, Naveen Pemmaraju, Andrew A Lane, Laura Torres-Mi?ana, James E Thompson, Marina Y Konopleva, Callum M Sloss, Krystal Watkins, Gaurav Bedse, Yining Du, Kara E Malcolm, Patrick A Zweidler-McKay, Hagop M Kantarjian
doi : 10.1016/S1470-2045(23)00674-5
Volume 25, Issue 3, March 2024, Pages 388-399
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study
Aditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, Mustafa Ahmed Mahmutoglu, Chandrakanth J Preetha, Erich Kobler, Irada Pflüger, Marianne Schell, Katerina Deike-Hofmann, Tobias Kessler, Martin J van den Bent, Ahmed Idbaih, Michael Platten, Alba A Brandes, Burt Nabors, Roger Stupp, Denise Bernhardt, Jürgen Debus, Amir Abdollahi, Thierry Gorlia, J?rg-Christian Tonn, Michael Weller, Klaus H Maier-Hein, Alexander Radbruch, Wolfgang Wick, Martin Bendszus, Hagen Meredig, Felix T Kurz, Philipp Vollmuth
doi : 10.1016/S1470-2045(23)00641-1
Volume 25, Issue 3, March 2024, Pages 400-410
Radiotherapy trial quality assurance processes: a systematic review
Chloe Brooks, Elizabeth Miles, Peter J Hoskin
doi : 10.1016/S1470-2045(23)00625-3
Volume 25, Issue 3, March 2024, Pages e104-e113
Non-surgical ablation for breast cancer: an emerging therapeutic option
Masakazu Toi, Takayuki Kinoshita, John R Benson, Ismail Jatoi, Masako Kataoka, Wonshik Han, Chikako Yamauchi, Takashi Inamoto, Masahiro Takada
doi : 10.1016/S1470-2045(23)00615-0
Volume 25, Issue 3, March 2024, Pages e114-e125
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications
Simone N Koole, Atse H Huisman, Lonneke Timmers, Hans M Westgeest, Edwin van Breugel, Gabe S Sonke, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani
doi : 10.1016/S1470-2045(23)00592-2
Volume 25, Issue 3, March 2024, Pages e126-e135
Paraneoplastic dermatoses in a patient with gastric adenocarcinoma: cutaneous clues to internal malignancy
Tai-Li Chen*, Tsung-Hsien Chang*, Cheng-Yuan Li
doi : 10.1016/S1470-2045(24)00017-2
Volume 25, Issue 3, March 2024, Page e136
